Are there monogenic hereditary forms of bladder cancer or only genetic susceptibilities?

Bladder cancer (BC) is the most common cancer involving the urinary system and the ninth most common cancer worldwide. Tobacco smoking is the most important environmental risk factor of BC. Several single nucleotide polymorphisms have been validated by genome-wide association studies as genetic risk factors for BC. However, the identification of DNA mismatch-repair genes, including MSH2 in Lynch syndrome and MUTYH in MUTYH-associated polyposis, raises the possibility of monogenic hereditary forms of BC. Moreover, other genetic mutations may play a key role in familial and hereditary transmissions of BC. Therefore, the aim of this review is to focus on the major hereditary syndromes involved in the development of BC and to report BC genetic susceptibilities established with genome-wide significance level.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:22

Enthalten in:

Pharmacogenomics - 22(2021), 10 vom: 01. Juli, Seite 619-628

Sprache:

Englisch

Beteiligte Personen:

Souaid, Tarek [VerfasserIn]
Hindy, Joya-Rita [VerfasserIn]
Diab, Ernest [VerfasserIn]
Kourie, Hampig Raphael [VerfasserIn]

Links:

Volltext

Themen:

Bladder cancer
Genetics
Hereditary
Journal Article
Lynch
Review
Syndrome

Anmerkungen:

Date Completed 10.02.2022

Date Revised 10.02.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.2217/pgs-2020-0165

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM325934118